BioHarvest Sciences Inc. (BHST)
NASDAQ: BHST · Real-Time Price · USD
2.160
+0.020 (0.93%)
Jul 31, 2026, 4:00 PM EDT - Market closed
BioHarvest Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.17 | 23.03 | 2.39 | 5.36 | 1.74 | 4.12 |
Short-Term Investments | 1 | - | - | - | - | - |
Cash & Short-Term Investments | 20.17 | 23.03 | 2.39 | 5.36 | 1.74 | 4.12 |
Cash Growth | 493.00% | 863.39% | -55.37% | 208.47% | -57.83% | 130.90% |
Accounts Receivable | 3.18 | 2.92 | 1.81 | 1.23 | 1.21 | 0.62 |
Inventory | 4.97 | 4.56 | 3.66 | 2.47 | 1.38 | 0.93 |
Total Current Assets | 28.32 | 30.5 | 7.86 | 9.05 | 4.32 | 5.67 |
Net Property, Plant & Equipment | 16.8 | 16.73 | 16.77 | 5.77 | 4.91 | 4.36 |
Other Long-Term Assets | 0.44 | 0.43 | 0.37 | 0.18 | 0.16 | 0.18 |
Total Assets | 45.56 | 47.67 | 25 | 15 | 9.39 | 10.21 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.31 | 4.8 | 7.13 | 3.85 | 2.81 | 2.15 |
Accrued Expenses | 0.33 | 0.39 | 0.4 | 0.46 | 0.16 | 0.14 |
Short-Term Debt | 1.73 | 0.15 | 3.91 | - | - | - |
Current Portion of Long-Term Debt | - | - | - | 20.53 | 8.55 | - |
Current Portion of Leases | 1.27 | 1.41 | 0.77 | 0.38 | - | - |
Unearned Revenue | 0.47 | 0.49 | 0.91 | 0.72 | - | - |
Other Current Liabilities | 0.46 | 0.45 | 1.14 | 0.53 | - | 0.64 |
Total Current Liabilities | 9.58 | 7.68 | 14.26 | 26.47 | 11.52 | 2.92 |
Long-Term Debt | 0.79 | 2.42 | - | - | - | - |
Long-Term Leases | 10.25 | 10.13 | 9.14 | 1.43 | 1.67 | 2.27 |
Other Long-Term Liabilities | 1.92 | 1.98 | 0.27 | 1.96 | 2.13 | 2.16 |
Total Long-Term Liabilities | 12.96 | 14.53 | 9.41 | 3.39 | 3.8 | 4.43 |
Total Liabilities | 22.54 | 22.22 | 23.67 | 29.86 | 15.32 | 7.35 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 133.22 | 133 | 97.75 | 68.65 | 65.01 | 62.56 |
Retained Earnings | -110.19 | -107.55 | -96.42 | -83.51 | -70.94 | -59.71 |
Shareholders' Equity | 23.02 | 25.45 | 1.33 | -14.85 | -5.93 | 2.86 |
Total Liabilities & Equity | 45.56 | 47.67 | 25 | 15 | 9.39 | 10.21 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 14.04 | 14.1 | 13.82 | 22.34 | 10.22 | 2.27 |
Net Cash (Debt) | 6.13 | 8.92 | -11.43 | -16.99 | -8.48 | 1.84 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.31 | 0.48 | -0.71 | -1.25 | -0.65 | 0.15 |
Book Value | 23.02 | 25.45 | 1.33 | -14.85 | -5.93 | 2.86 |
Book Value Per Share | 1.17 | 1.38 | 0.08 | -1.10 | -0.45 | 0.23 |
Tangible Book Value | 23.02 | 25.45 | 1.33 | -14.85 | -5.93 | 2.86 |
Tangible Book Value Per Share | 1.17 | 1.38 | 0.08 | -1.10 | -0.45 | 0.23 |